Designing a global monitoring system for pilot introduction of a new contraceptive technology, subcutaneous DMPA (DMPA-SC).

•From 2014 to 2016, the MOHs of Burkina Faso, Niger, Senegal and Uganda launched pilot introductions of the novel injectable contraceptive DMPA-SC.•This manuscript describes a four-phase approach to monitoring DMPA-SC pilot introduction across the four countries.•Existing national family planning registers were used to monitor DMPA-SC pilot introductions, with modifications.•Comprehensive data from DMPA-SC pilot introduction informed decisions about future investments in the product and scaling product availability nationally.